Provided are quinazolinone compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof:wherein R7, R8, and R9 are as defined herein. Methods of use, and pharmaceutical compositions of these compounds are also disclosed herein.